Does a patient with a previously estimated Glomerular Filtration Rate (eGFR) in the high 50s, now with a combined eGFR of approximately 64 mL/min/1.73 m², have Chronic Kidney Disease (CKD) if their kidney function improves and eGFR rises above 60 mL/min/1.73 m² permanently?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CKD Diagnosis Clarification: eGFR Thresholds and Reversibility

You Are Correct About the Stage 3a Threshold

You are absolutely correct that an eGFR of 64 mL/min/1.73 m² does not meet the diagnostic threshold for Stage 3a CKD, which requires eGFR below 60 mL/min/1.73 m². 1 The combined equation result of 64 mL/min/1.73 m² actually confirms that you do NOT have CKD based on eGFR criteria alone, assuming no other markers of kidney damage are present. 1

Understanding the CKD Diagnostic Framework

The diagnosis of CKD requires one of two conditions to be met for at least 3 months: 1

  • eGFR <60 mL/min/1.73 m² (sufficient alone, no additional markers needed)
  • eGFR 60-89 mL/min/1.73 m² PLUS documented kidney damage (albuminuria, pathological abnormalities on biopsy, urine abnormalities, or history of kidney transplantation) 1

Since your combined eGFR is 64 mL/min/1.73 m², you would only have CKD if you also have documented kidney damage markers present for ≥3 months. 1

The KDIGO Confirmation Strategy Explained

The KDIGO guidelines recommend measuring cystatin C specifically for patients with creatinine-based eGFR of 45-59 mL/min/1.73 m² who lack other markers of kidney damage. 2, 3 The confirmation algorithm works as follows:

  • If the combined equation (eGFRcreat-cys) is <60 mL/min/1.73 m²: CKD diagnosis is confirmed 2, 3
  • If the combined equation (eGFRcreat-cys) is ≥60 mL/min/1.73 m²: CKD diagnosis is NOT confirmed 2, 3

This strategy exists because approximately 23% of patients with creatinine-based eGFR in the 45-59 range actually have normal kidney function when confirmed with cystatin C. 1, 3

Does Temporary Stage 3a Mean Lifelong CKD?

No, a patient who temporarily had eGFR <60 mL/min/1.73 m² but subsequently maintains eGFR ≥60 mL/min/1.73 m² permanently does NOT have CKD for life, assuming no kidney damage markers persist. 1

The critical element is the 3-month duration requirement. CKD requires either: 1

  • Reduced eGFR (<60 mL/min/1.73 m²) persisting for ≥3 months, OR
  • Evidence of kidney damage persisting for ≥3 months

If kidney function improves and remains above 60 mL/min/1.73 m² permanently, and no kidney damage markers are present, the patient no longer meets diagnostic criteria for CKD. 1 This is particularly relevant because research shows that eGFR values in healthy adults can range as low as 63.5 mL/min/1.73 m², and these normal values overlap with CKD stages 1 and 2. 4

Important Caveats About eGFR Interpretation

The combined creatinine-cystatin C equation provides 94.9% accuracy within 30% of measured GFR and should be the definitive value used for clinical decision-making when discordance exists between creatinine-based and cystatin C-based estimates. 5 In your case, with a combined eGFR of 64 mL/min/1.73 m², this represents the most accurate assessment of your kidney function. 5

Normal GFR values are approximately 130 mL/min/1.73 m² for men and 120 mL/min/1.73 m² for women, with a mean decline of 0.75 mL/min/year with aging. 2 An eGFR >60 mL/min/1.73 m² does not exclude kidney disease if damage markers are present, but in the absence of such markers, it indicates you do not have CKD. 4

References

Guideline

CKD Diagnosis Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cystatin C Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Estimating Kidney Function using eGFR

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the management recommendations for a patient with a Glomerular Filtration Rate (GFR) of 49 mL/min/1.73m², indicating stage 3B Chronic Kidney Disease (CKD)?
What is the significance of an estimated Glomerular Filtration Rate (eGFR) of 12ml/min/1.73m2 in terms of kidney function?
What is the management approach for a patient with impaired renal function, specifically an estimated glomerular filtration rate (eGFR) of 40?
What does an eGFR (estimated Glomerular Filtration Rate) greater than 60 indicate?
What does the Glomerular Filtration Rate (GFR) lab test determine in a patient with chronic kidney disease?
What are the potential side effects of Minoxidil (minoxidil) in patients with androgenetic alopecia, especially those with a history of cardiovascular disease?
What is the best course of action for an adult patient with a renal mass and a positive PET (Positron Emission Tomography) FDG (Fluorodeoxyglucose) scan, considering possible primary renal cell carcinoma or metastatic disease?
What is the recommended titration schedule for an adult patient with no significant renal or hepatic impairment starting carbamazepine (Tegretol) 100mg three times a day (TID)?
What could be the cause of a 0.9cm decrease in testicle length, from 4cm to 3.1cm, over a 4-week period, as shown on two ultrasound scans (USS) of my testicles?
What is the significance of a significantly elevated alkaline phosphatase (ALP) level of 700 in a pregnant female with normal bilirubin levels?
What is the role of hemoadsorption in the treatment of patients with intrahepatic cholestasis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.